The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be. Diagnostic and Therapeutic Center of Athens Hygeia SA (ATSE:HYGEIA) currently has a Q.i. Value of 18.00000. Investors often have a large selection of stocks to research when looking to add to the portfolio. Investors have the ability to employ many different strategies to help beat the stock market. In the end, the main goal is typically to maximize profits while minimizing risk. Investors commonly strive to diversify the portfolio in order to minimize risk. Most serious investors are well aware of the risks when entering the equity market. Investors may choose to own stocks across multiple industries to keep from having all the eggs in one basket. Others may choose companies of different size, and even delve into foreign markets. Finding those hidden gems in the stock market may not be the easiest of chores. Investors may have to spend many hours doing the research and crunching the numbers.
Checking in on some valuation rankings, Diagnostic and Therapeutic Center of Athens Hygeia SA (ATSE:HYGEIA) has a Value Composite score of 20. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales.
The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 26.
Watching some historical volatility numbers on shares of Diagnostic and Therapeutic Center of Athens Hygeia SA (ATSE:HYGEIA), we can see that the 12 month volatility is presently 43.002000. The 6 month volatility is 47.721900, and the 3 month is spotted at 44.899600.
Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period.
We can now take a quick look at some historical stock price index data. Diagnostic and Therapeutic Center of Athens Hygeia SA (ATSE:HYGEIA) presently has a 10 month price index of 2.38356. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period.
Looking at some alternate time periods, the 12 month price index is 2.38356, the 24 month is 3.48000, and the 36 month is 1.18771. Narrowing in a bit closer, the 5 month price index is 1.53304, the 3 month is 1.17568, and the 1 month is currently 0.90155.
Diagnostic and Therapeutic Center of Athens Hygeia SA (ATSE:HYGEIA) has a current ERP5 Rank of 7361. The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.